Insulin-like growth factor binding protein-related protein 1 (IGFBPrP1) contributes to liver inflammation and fibrosis via activation of the ERK1/2 pathway

Hepatology International
Yarong GuoLi-xin Liu

Abstract

Previously, we suggested that IGFBPrP1 played a major role in hepatic stellate cell (HSC) activation, yet the molecular mechanism of IGFBPrP1 in hepatic fibrosis is unclear. The ERK pathway is involved in activation of HSCs. This study investigated the involvement of the ERK1/2 pathway in IGFBPrP1-induced liver inflammation and fibrosis. An adenoviral vector encoding IGFBPrP1 (AdIGFBPrP1) was constructed. Rats received AdIGFBPrP1 or CAd (vector control) via their tail vein injection. One hour prior to adenoviral injections, rats were intraperitoneally administrated with 10 mg/kg U0126 (a specific MEK/ERK1/2 inhibitor) or DMSO (vehicle control). At weeks 2 or 4 post-gene transduction, serum samples were obtained and the levels of liver enzymes and hydroxyproline were determined. Liver tissue were histologically evaluated for inflammation and fibrosis. The expression of α-SMA and ECM were evaluated by qRT-PCR and western blotting. After transduction, IGFBPrP1 expression significantly increased in livers and transduced cells. MEK/ERK1/2 inhibition administration of AdIGFBPrP1-treated rats and cells significantly blocked AdIGFBPrP1-induced activation of ERK1/2. U0126 significantly down-regulated the number of F4/80-positive cells a...Continue Reading

References

Dec 16, 1998·The Journal of Clinical Endocrinology and Metabolism·V HwaS R Plymate
Jan 25, 2000·The Journal of Biological Chemistry·S L Friedman
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tomoko HayashidaH William Schnaper
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daisuke NagakuboMasayuki Miyasaka
Feb 7, 2004·Molecular Biotechnology·Hiroki MaruyamaFumitake Gejyo
Feb 4, 2005·The Journal of Clinical Investigation·Ramón Bataller, David A Brenner
Aug 18, 2005·Journal of Cell Science·Aristidis Moustakas, Carl-Henrik Heldin
Sep 6, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shigeki TsukadaRichard A Rippe
Aug 2, 2006·EMBO Reports·Satoko Nishimoto, Eisuke Nishida
Mar 3, 2007·The Journal of Clinical Investigation·John P Iredale
Jun 1, 2007·General and Comparative Endocrinology·Buel D RodgersCullen Thompson
Aug 30, 2007·Cellular and Molecular Life Sciences : CMLS·Y Zhang, C Dong
May 13, 2008·Gastroenterology·Scott L Friedman
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Dec 3, 2008·Neoplasia : an International Journal for Oncology Research·Wei JiangTom Mikkelsen
Mar 28, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Junji MaHuiqing Jiang
Apr 25, 2009·Molecular Pharmaceutics·Kun ChengRam I Mahato
Jul 29, 2010·Seminars in Liver Disease·Hermann E WasmuthChristian Trautwein
Jun 28, 2011·Cell and Tissue Research·Yabing MuMaréne Landström
Jan 22, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Ana Tapia-AbellánMaría Martínez-Esparza
Jan 1, 2014·Journal of Digestive Diseases·Xiao Hong GuoZhi Hong Qiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.